Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion type Assertion NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_head.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion description "[Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion evidence source_evidence_literature NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion SIO_000772 25130256 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion wasDerivedFrom befree-2016 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion wasGeneratedBy ECO_0000203 NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.